Association of red cell distribution width to albumin ratio with risk of all-cause and cause-specific mortality: two prospective cohort studies

Meng Hao, Shuai Jiang, Xiangnan Li, Shu‐Ming Wang, Yi Li, Jingdong Tang, Zixin Hu, Hui ZhangmedRxiv 2024 · DOI

TL;DR

The Red Cell Distribution Width to Albumin Ratio (RAR) is a powerful, low-cost prognostic marker for mortality. By analyzing data from nearly half a million people, researchers found that a higher RAR is strongly and independently linked to an increased risk of death from all causes, including cancer, heart disease, and respiratory illnesses.

What Problem Does This Paper Address?

Clinicians are constantly searching for simple, inexpensive, and reliable biomarkers to identify individuals at high risk of mortality. While many "novel" biomarkers exist, they are often expensive or require specialized testing.

This paper focuses on two routine laboratory measures: Red Cell Distribution Width (RDW), which measures the variation in size of red blood cells and reflects inflammation and oxidative stress, and Serum Albumin, a protein that indicates nutritional status and liver/kidney function. While both are known individual markers of health, this study investigates whether their ratio (RAR) can serve as a more robust, "integrative" indicator of physiological dysfunction and mortality risk in the general population.

Methods

The researchers conducted a prospective cohort study using two massive, well-established datasets. They employed several standard but rigorous statistical techniques:

  • Cox Proportional Hazard Models: Used to estimate the Hazard Ratio (HR)—the relative risk of death—associated with different RAR levels while adjusting for "confounders" like age, smoking, BMI, and pre-existing conditions.
  • Restricted Cubic Spline (RCS) Regressions: Applied to model the dose-response relationship, allowing the researchers to see if the risk increases linearly or follows a more complex curve.
  • Kaplan-Meier Survival Curves: Used to visualize the probability of survival over time for different RAR groups (quartiles).

The "novelty" here isn't a new algorithm, but rather the large-scale validation of a simple derived ratio across two distinct international populations.

Datasets

The study utilized two major longitudinal datasets:

  1. US NHANES (1988-2018): 50,622 participants aged 18+, with a median follow-up of 9.4 years.
  2. UK Biobank: 418,950 participants aged 37+, with a median follow-up of 14.5 years.

Using both a US and a UK cohort provides a high level of external validity, suggesting the findings are generalizable across different demographics and healthcare systems.

Key Insights and Ideas

  • The "Integrative" Advantage: RAR acts as a proxy for a "multidimensional dysfunctional physiological status." It captures the intersection of inflammation (via RDW) and nutritional/antioxidant depletion (via Albumin).
  • Linear Risk Profile: The RCS analysis revealed a linear positive relationship. There isn't a "safe" threshold where risk levels off; as RAR goes up, the risk of mortality increases steadily.
  • Universal Predictor: Surprisingly, RAR wasn't just linked to one type of death. It significantly predicted mortality across a wide spectrum: malignant neoplasms (cancer), heart disease, cerebrovascular diseases, respiratory diseases, and diabetes.
  • Clinical Accessibility: Because RDW and Albumin are part of standard blood panels, RAR can be calculated automatically by electronic health records without any additional cost to the patient or the provider.

Key Results

The quantitative findings were remarkably consistent across both cohorts:

  • All-Cause Mortality: In the multivariable-adjusted model, higher RAR was associated with a significantly higher risk of death.
  • NHANES: Hazard Ratio (HR) of 1.86 (95% CI: 1.81-1.93).
  • UK Biobank: HR of 2.01 (95% CI: 1.96-2.06).
  • Quartile Comparison: When comparing the highest 25% of RAR scores to the lowest 25%, the risk of death was more than double in the NHANES group (HR 2.26).
  • Cause-Specific Mortality: The associations remained significant for almost all underlying causes. For example, in the UK Biobank, the HR for respiratory disease mortality was 2.80, and for heart disease, it was 2.32.

Limitations and Future Work

  • Correlation vs. Causation: As an observational study, this research shows a strong association but cannot prove that a high RAR causes an increased risk of death.
  • Single Snapshot: RAR was measured only at the baseline. The study does not account for how a person's RAR might change over time (trajectories) and how those changes correlate with health outcomes.
  • Residual Confounding: While the authors adjusted for many factors (age, BMI, etc.), there may be unmeasured variables (like specific genetic markers or environmental exposures) that influence both RAR and mortality.
  • Future Directions: The authors suggest that future studies should validate these findings in even more diverse populations and investigate the causal mechanisms—specifically how chronic inflammation and nutrition interact to drive these outcomes.

Summary updated

Abstract

Abstract Background The red cell distribution width to albumin ratio (RAR) has emerged as a reliable prognostic marker for mortality in various diseases. However, whether RAR is associated with mortality remains unknown in the general population. Objective Explore whether RAR is associated with all-cause and cause-specific mortality, and to elucidate the dose-response relationship between them. Methods This study included 50622 participants aged 18+ years from US National Health and Nutrition Examination Survey (NHANES), and 418950 participants aged 37+ years from UK Biobank. The potential association between RAR and the risk of all-cause and cause-specific mortality was evaluated by Cox proportional hazard models. Restricted cubic spline regressions were applied to estimate the possible nonlinear relationships. Results NHANES documented 7590 deaths over a median follow-up of 9.4 years, and UK Biobank documented 36793 deaths over a median follow-up of 14.5 years. In multivariable analysis, elevated RAR were significantly associated with a higher risk of all-cause mortality (NHANES: hazard ratio [HR]: 1.86, 95% confidence interval [CI]: 1.81-1.93; UK Biobank: HR: 2.01, 95% CI: 1.96-2.06), as well as mortality due to malignant neoplasms, heart disease, cerebrovascular diseases, respiratory diseases, diabetes mellitus, and others in both the two cohorts (all P-value < 0.05). Conclusions Higher baseline RAR was strongly and independently associated with increased risk of all-cause and cause-specific mortality in the general population. RAR was a promising indicator that simply, reliably, and inexpensively accessible for identifying high-risk of mortality in clinical practice.
BibTeX
@misc{hao2024association,
  author = {Meng Hao and Shuai Jiang and Xiangnan Li and Shu‐Ming Wang and Yi Li and Jingdong Tang and Zixin Hu and Hui Zhang},
  title = {{Association of red cell distribution width to albumin ratio with risk of all-cause and cause-specific mortality: two prospective cohort studies}},
  year = {2024},
  doi = {10.1101/2024.01.10.24301123},
  howpublished = {medRxiv},
}
Figure